The US FDA has requested that AstraZeneca make modifications to the Ultomiris RE...
Amid financial issues, Idorsia is hoping the resistant hypertension drug would b...
The country returns to the EU’s research programme after a Brexit-related absenc...
Patient information on the Janssen CarePath was accessed, but the true extent of...
Cidara will also receive $7m in milestone payments for the drug-Fc conjugate as ...
Veracyte has announced a partnership with Gustave Roussy to support biopharmaceu...
IMIDomics has entered an agreement to license TNAX Biopharma’s IMB1001 to treat ...
Novo Nordisk has entered a collaboration with The Broad Institute to detect drug...
Portfolio biopharmaceutical company Apollo Therapeutics has secured $226.5m in a...
Nimbus plans to use these funds to aid new drug discovery efforts and plans to c...
"We were bullied into unfair and undemocratic terms in contracts that were total...
A lot turns on what “bona fide competition” means.
“We could reduce right now cancer by 50% in the next 25 years by active navigati...
Republicans on three key House committees have reconciled differing legislative ...
More older adults have been hospitalized for Covid-19 over the past several week...
Astellas was so sure that one of its drugs was going to be selected as part of M...
